Howard University Cancer Center CCOP

Washington D.C., District of Columbia 20060

0 studies enrolling now · 1 studies all time

What they study most

Adult Solid Neoplasm, Inflammatory Breast Carcinoma, Male Breast Carcinoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer

Studies at this site

• Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer — Completed